Kontafarma China Holdings Limited
Research Kontafarma China Holdings Limited (1312.HK) on Bullrun: market cap HKD 178.83M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1312.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 178.83M
- Financial periodFY2025
- RevenueHKD 914.71M
- Revenue growth1.9%
- Net income-HKD 427.85M
- Free cash flowHKD 53.15M
- Gross margin56.2%
Valuation Snapshot
latest market cap is HKD 178.83M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 914.71M | -HKD 427.85M | HKD 53.15M | 56.2% | n/a | HKD 66.06M | HKD 203.68M | HKD 553.27M |
| FY2024 | HKD 897.52M | -HKD 75.54M | HKD 33.41M | 57.5% | -0.01 | HKD 80.59M | HKD 297.19M | HKD 978.70M |
| FY2023 | HKD 809.11M | -HKD 28.84M | HKD 12.92M | 58.2% | -0.01 | HKD 77.66M | HKD 333.82M | HKD 1.06B |
| FY2022 | HKD 894.06M | -HKD 41.55M | -HKD 53.84M | 56.6% | -0.01 | HKD 122.60M | HKD 590.72M | HKD 1.10B |
| FY2021 | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | HKD 178.83M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Kontafarma China Holdings Limited
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally. The company operates through Pharmaceutical Business and Fitness Business segments. It provides prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kontafarma China Holdings Limited's market cap?
Kontafarma China Holdings Limited's market capitalization is HKD 178.83M.
What does Kontafarma China Holdings Limited do?
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally. The company operates through Pharmaceutical Business and Fitness Business segments. It provides prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities.